| # | Drug | Count |
|---|---|---|
| 0 | MISOPROSTOL | 7 |
| 1 | ADALIMUMAB | 4 |
| 2 | MACITENTAN | 4 |
| 3 | 0XYGEN | 3 |
| 4 | OXYGEN | 3 |
| 5 | SELEXIPAG | 3 |
| 6 | TADALAFIL | 3 |
| 7 | WARFARIN | 3 |
| 8 | ACETAMINOPHEN | 2 |
| 9 | BISOPROLOL FUMARATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | I. V. FAT EMULSION | 1 | 0.0014 |
| 1 | POTASSIUM IODIDE | 2 | 0.0013 |
| 2 | MISOPROSTOL | 7 | 0.0007 |
| 3 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 4 | OXYTOCIN | 1 | 0.0003 |
| 5 | IDURSULFASE | 1 | 0.0003 |
| 6 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 7 | DOXEPIN HYDROCHLORIDE | 2 | 0.0002 |
| 8 | SELEXIPAG | 3 | 0.0001 |
| 9 | ETONOGESTREL AND ETHINYL ESTRADIOL | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostaglandin E1 Analog [EPC] | 7 |
| 1 | Endothelin Receptor Antagonist [EPC] | 4 |
| 2 | Estrogen [EPC] | 4 |
| 3 | Corticosteroid [EPC] | 3 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 3 |
| 5 | Progestin [EPC] | 3 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 3 |
| 7 | Aromatase Inhibitor [EPC] | 2 |
| 8 | Benzodiazepine [EPC] | 2 |
| 9 | Insulin Analog [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostaglandin E1 Analog [EPC] | 7 | 0.0004 |
| 1 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 2 | Oxytocic [EPC] | 1 | 0.0003 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Androgen [EPC] | 1 | 0.0000 |
| 6 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Estrogen [EPC] | 4 | 0.0000 |
| 9 | Endothelin Receptor Antagonist [EPC] | 4 | 0.0000 |